http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108969525-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bf415258683635c3e869f8fdd14bb250 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5415 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-02 |
| filingDate | 2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_74d7ef13090f29dd09792c82694ff3c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d60888583c44c4b1e5a46713309f78e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a53311cf9966978acd9d498a77dead3 |
| publicationDate | 2018-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108969525-A |
| titleOfInvention | For treating the composition and preparation method of post-herpetic neuralgia |
| abstract | The present invention relates to the composition and preparation method for treating post-herpetic neuralgia, the composition includes methylenum careuleum and Ropivacaine.Specifically, further relate to a kind of method for treating post-herpetic neuralgia, this method includes to subject in need through a effective amount of pharmaceutical composition comprising methylenum careuleum and Ropivacaine of painful area dermal administration, and wherein methylenum careuleum and the weight ratio of Ropivacaine are 1:0.5~2.Described pharmaceutical composition is the external medicine preparation of transdermal administration, such as gel emplastrum, Babu cream.Using the present composition and method treatment post-herpetic neuralgia have the characteristics that method simplicity, do not inject, hurtless measure, almost without side-effects, safe and effective, tolerance is good. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114533658-A |
| priorityDate | 2018-09-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.